Role of Pulmonary Vasodilators in Ameliorating Primary Graft Dysfunction Following Lung Transplant

JAMA Surg. 2022 Jan 1;157(1):e215857. doi: 10.1001/jamasurg.2021.5857. Epub 2022 Jan 12.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Lung Transplantation* / adverse effects
  • Primary Graft Dysfunction*
  • Risk Factors
  • Vasodilator Agents / therapeutic use

Substances

  • Vasodilator Agents